InvestorsHub Logo

xoc

Followers 13
Posts 303
Boards Moderated 0
Alias Born 04/20/2010

xoc

Re: Here Today post# 322665

Tuesday, 09/08/2020 11:15:11 PM

Tuesday, September 08, 2020 11:15:11 PM

Post# of 402722
Perhaps we can expect more information on preclinical work in Italy on pancreatic cancer and GBM

From press release 3/3/17
"In related news: Last week, Cellceutix research partners in Italy shared results with the Company from their ongoing preclinical work evaluating Kevetrin in Acute Myeloid Leukemia (AML), Pancreatic Cancer and human Gliobastoma Multiforme (hGBM). The data will be presented (by them) at scientific conferences, and is consistent with, and further informs, our knowledge of Kevetrin. "
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News